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S2 (1) Materials and methods
Reactions were monitored by thin layer chromatography (TLC) on silica gel ALUGRAM Xtra SIL G/UV 254 plates. Visualization was performed under UV (254 nm) or by staining with a solution of KMnO 4 and subsequent heating. Purification of crude products was performed by flash chromatography on silica gel (0.040-0.63 mm, Fluka Analytical 60752 silica gel 60, 230-400 mesh) or on aluminum oxide 5016-A-I Basic from CAMAG and then monitored with POLYGRAM ALOX N/UV 254 plates from Macherey-Nagel. 1 H-NMR and 13 C spectra were recorded at 300 and 400 MHz and 75 and 100 MHz respectively, on a Bruker Avance 300 and DPX-400. Chemical shifts are reported in  (ppm) and the residual signal of the solvent was used as the internal standard (CDCl 3 1 H:  = 7.26 ppm, 13 C:  = 77.0 ppm, CD 3 OD 1 H:  = 3.31 ppm, 13 C:  = 49.1 ppm, D 2 O 1 H:  = 4.79 ppm). HSQC spectra were recorded on a Bruker Avance 400 spectrometer. High resolution mass spectra were obtained using Electro spray ionization mass (MS-ESI) technique on a Applied Biosystems Sciex QSTAR Pulsar (hybrid quadrupole time-of-flight mass spectrometer) instrument. Infrared spectra (IR) were recorded on a Jasco FT-IR-460 Plus spectrometer equipped with a Specac MKII Golden Gate Single Reflection Diamond ATR System neat or as film with CH 2 Cl 2 . Reverse phase purification was done with preparative-LC, Waters PrepLC System and UV detection at 214 nm. Purity of the compounds was determined by UPLC on a Dionex Ultimate 3000 using a C8 or a C18 reversed-phase column, the gradient used were 100% A to 100% D over 5 min. or 70% A 30% D to 100% D over 6 min (A = 100% water with 0.1% of trifluoroacetic acid and D = 40% water with 60% acetonitrile and 0.1% trifluoroacetic acid). Purity of some compounds was also determined by reversed-phase HPLC (Zorbax Eclipse XDB-C18, 5µm, 4.6 × 150 mm) using a MeOH/H 2 O solvent system. Compounds were eluted with a gradient of 35% MeOH/H 2 O to 100% MeOH with 1% NH 4 OH for 55 min at a flow rate of 1 ml/min. Purity was determined by total absorbance at 254 nm. Lyophilizations were performed with a Christ Alpha 2-4 LD plus device.
Solvents and reagents were purchased from Sigma, Aldrich, Fluka, Acros and Alfa Aesar and used without further purification. Anhydrous solvents were used preferentially for reactions. Reactions were always performed under inert atmosphere (N 2 ).
(2) Synthesis of N1-linked granisetron conjugates

N-(3-bromopropyl)-7-nitrobenzo[c][1,2,5]oxadiazol-4-amine (23)
To a solution of 3-Bromopropylamine hydrobromide (0.2 g, 0.92 mmol) in THF/H 2 O (4:1, 10 ml) was added Et 3 N (0.27 g, 2.7 mmol), followed by NBD-Cl (0.27 g, 1.4 mmol), the mixture was then stirred at room temperature. The reaction was carried out in the absence of light. The progress of the reaction was monitored by TLC and completed in 24 h. The solvents were removed in vacuo and the reaction mixture was extracted with EtOAc (3×20 ml) and washed with water. The combined organic phases were dried over Na 2 SO 4 , filtered and concentrated to give the crude product. The crude product was further purified by flash column chromatography (EtOAc/hexane; 1.5:8.5) to afford 23 (0.25 g, 0.83 mmol, 91%) as a yellow solid: mp 78-80°C. R f = 0.04 (EtOAc/hexane; 2:8). IR (neat): 3369, 1578,
N-(3-bromopropyl)-5-(dimethylamino)naphthalene-1-sulfonamide (24)
To a solution of 3-Bromopropylamine hydrobromide (0.19 g, 0.88 mmol) in CH 2 Cl 2 (10 ml) was added Et 3 N (0.27 g, 2.7 mmol) followed by dansylchloride (0.2 g, 0.74 mmol), the mixture was stirred at room temperature. The reaction was carried out in the absence of light. The progress of the reaction was monitored by TLC and completed in 12 h. The reaction mixture was diluted with CH 2 Cl 2 (10 ml) and washed with aqueous Na 2 CO 3 (5 ml). The CH 2 Cl 2 -layer was dried over Na 2 SO 4 , filtered and concentrated to give the crude product. The crude product was further purified by flash column chromatography (EtOAc/hexane; 1:9) to afford 24 (0.25 g, 0.68 mmol, 91%) as a green oil: R f = 0.08 (EtOAc/hexane; 2:8 [M+H] + , found 371.0423 [M+H] + ; Anal.calcd C 48.52%, H 5.16%, N 7.54%, found C 48.37%, H 5.08%, N 7.63%.
1-(3-(5-(dimethylamino)naphthalene-1-sulfonamido)propyl)-N-((endo)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)-1H-indazole-3-carboxamide (27)
Amide 7 (0.1 g, 0.34 mmol) was dissolved in dry DMF/THF (1:5, 5 mL), cooled to 0°C and stirred for 5 min. Then a solution of t-BuOK (0.053 g, 0.44 mmol) in dry THF (1 ml) was added drop-wise at 0°C and stirred for 15 min, followed by a solution of compound 24 (0.14 g, 0.37 mmol) in dry THF (1 ml), the mixture was warmed to room temperature and stirred for 12h. The reaction was carried out in the absence of light and under N 2 atmosphere. The progress of the reaction was monitored by TLC. The solvents were removed in vacuo and the crude product was purified by flash column chromatography ( 4-bromobutanoyl chloride (1.52 g, 16.0 mmol) was added drop-wise to a stirred solution of 2,4-dimethylpyrrole (2.22 g, 12.0 mmol) in CH 2 Cl 2 (60 ml) and the mixture was heated at 50°C for 2 h. After evaporation of the solvent, toluene (150ml), CH 2 Cl 2 (10 ml) and DIEA (9.2 g, 0.072) were added to the solid and the mixture was stirred at room temperature for 30 min. followed by addition of BF 3 •Et 2 O (16.9 g, 120 mmol). The reaction mixture was heated at 50°C for 1.5 h. The solvents were removed in vacuo and the residue was extracted with CH 2 Cl 2 (3×30 ml) and washed with 2M NaOH. The combined organic phases were dried over Na 2 SO 4 , filtered and concentrated to give the crude product. The crude product was further purified by flash column chromatography (EtOAc/hexane; 1:9) to afford 25 (0. [M+H] + ; Anal.calcd C 52.78%, H 5.76%, N 6.15%, found C 53.29%, H 5.77%, N 6.18%. Crystal structure vide infra. Amide 7 (0.14 g, 0.47 mmol) was dissolved in dry DMF/THF (1:5, 8 ml), cooled to 0°C and stirred for 5 min. Then a solution of t-BuOK (0.063 g, 0.52 mmol) in dry THF (1 ml) was added dropwise at 0°C and stirred for 15 min, followed by a solution of compound 25 (0.32 g, 0.7 mmol) in dry THF (2 mL). The mixture was warmed up to room temperature and stirred for 12 h. The progress of the reaction was monitored by TLC. The solvents were removed in vacuo and the aqueous layer was extracted with CH 2 Cl 2 (3×20 ml). The combined organic phases were dried over Na 2 SO 4 To a solution of amine 11•2 HCl 13 (6.0 mg, 0.016 mmol) in dry DMF (0.5 ml) was added DIEA (4.1 mg, 0.032 mmol), the mixture was stirred for 10 min. Then a solution of BODIPY TMR-X succinimidyl ester (5.0 mg, 0.008 mmol) in DMF (1 ml) was added to the mixture and stirred at room temperature for 3.5 h. The progress of the reaction was monitored by TLC. DMF was removed in vacuo and the crude product was purified by flash column chromatography ( Coumarin carboxylic acid (0.03 g, 0.115 mmol, 1 eq.), DCC (0.03 g, 0.149 mmol, 1.3 eq.) and HOBt (0.015 g, 0.115 mmol, 1 eq.) were put together with a stirrer in a two-neck round bottom flask and dried under high vacuum for 1 h. This mixture was then dissolved in dry DMF/CH 2 Cl 2 (1:4, 5 ml) and stirred for 2 h at room temperature under N 2 atmosphere. A solution of amine 11•2 HCl (0.054 g, 0.126 mmol) mixed with Et 3 N (0.032 ml, 0.23 mmol, 2 eq.) in dry CH 2 Cl 2 (2 ml) was added dropwise to the mixture and left stirring for 24 h at RT. The solvents were removed in vacuo and the crude product was extracted with CH 2 Cl 2 (3×15ml) and washed with NaHCO 3 sat. The combined organic layers were dried over Na 2 SO 4 , filtered and concentrated to yield the crude product. The crude product was further purified by flash chromatography on silica gel (CH 2 Cl 2 /MeOH/Et 3 N, 96:3:1). The product was then washed with water (4 ml), NaHCO 3 sat. ( 
2-(6-Hydroxy-3-oxo-3H-xanthen-9-yl)-5-(3-(3-(3-(9-methyl-9-azabicyclo [3.3.1]nonan-3-yl)carbamoyl)-1H-indazol-1-yl)propyl)thioureido)benzoic acid (16)
To a stirred solution of amine 11•2 HCl (0.032 g, 0.074 mmol, 1 eq.) in DMF (1 ml) was added Et 3 N (61 µl, 0.294 mmol, 6 eq.) and fluorescein isothiocyanate (0.03 g, 0.077 mmol, 1.05 eq.). The mixture was reacted for 4.5 h at room temperature. The solvent was removed under high vacuum. The crude product was purified by prep-LC, using a gradient of 100% A (100% water with 0. 
Synthesis of linker building block 9:
tert-Butyl (4-hydroxybutyl)carbamate 4-amino-1-butanol (0.5 g, 5.61 mmol) was dissolved in acetonitrile (56 ml). The solution was cooled to 0°C and Et 3 N (1.56 ml, 11.22 mmol, 2 eq.) was added followed by Boc 2 O (1.346 g, 6.17 mmol). The reaction was followed by TLC and quenched with water (20 ml) after 6.5 h. The solution was extracted with EtOAc (3×30ml), brine was used to help phase separation. The combined organic layers were dried over Na 2 SO 4 , filtered and concentrated under reduced pressure. The crude product was purified by flash chromatography on silica gel (CH 2 Cl 2 /MeOH, 95:5) to give the title compound as a colorless oil ( tert-Butyl (4-hydroxybutyl)carbamate (1.06 g, 5.788 mmol) was dissolved in dry THF (54 ml) followed by addition of Ph 3 P (2.86 g, 10.92 mmol, 1.9 eq.). Then CBr 4 (3.62 g, 10.92 mmol, 1.9 eq.) was slowly added to the mixture. After 3 h the solution was filtered through a celite pad to eliminate the by-products and washed with Et 2 O. The solvents were removed under high vacuum. The crude product was purified by flash chromatography on silica gel (hexane/EtOAc, 3:1) to give 9 as a white solid at 5°C (1.73 g, quantitative yield): R f = 0.7 (hexane/EtOAc, 3:1 
tert-Butyl (4-(3-(((3-endo)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)carbamoyl)-1H-indazol-1-yl)butyl)carbamate
Amide 7 (0.215 g, 0.721 mmol) was dissolved in DMF/THF (1:5, 7.2 ml). The reaction was cooled to 0°C and stirred for 5 min. A solution of t-BuOK (0.089 g, 0.793 mmol, 1.1 eq) in dry THF (2ml) was added at 0°C and stirred 15 min. Then linker 9 (0.218 g, 0.865 mmol) in dry THF (2 ml) was added. The mixture was brought to room temperature and stirred overnight. Progress of the reaction was monitored by TLC. The solvents were removed in vacuo, water (20 ml) was added and the solution was extracted with EtOAc (3×20 ml). The combined organic layers were dried over Na 2 SO 4 
1-(4-Aminobutyl)-N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)-1H-indazole-3-carboxamide dihydrochloride (12)
To a solution of tert-butyl (4- (3-(((3-endo-) 
1-(4-(7-(Diethylamino)-2-oxo-2H-chromene-3-carboxamido)butyl)-N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)-1H-indazole-3-carboxamide (17)
Following procedure I; coumarin carboxylic acid (0.02 g, 0.079 mmol), DCC (0.021 g, 0.103 mmol, 1.3 eq.) and HOBt (0.01 g, 0.079 mmol, 1 eq.) were mixed in a twoneck round bottom flask in DMF/CH 2 Cl 2 . A solution of amine 12•2 HCl (0.032 g, 0.087 mmol) mixed with Et 3 N (0.02ml, 0.16 mmol, 2 eq.) in dry CH 2 Cl 2 (1.3 ml) was then added drop-wise. After work-up, the combined organic layers were dried over Na 2 SO 4 , filtered and concentrated to yield the crude product. The crude product was further purified by flash chromatography on silica gel (CH 2 Cl 2 /MeOH/Et 3 N, 96:3:1). The product was then washed with water (4 ml), NaHCO 3 sat. (3 ml) and extracted with CHCl 3 (3×15 ml) to remove triethylamine impurities and to give fluorescent ligand 17 (0.039 g, 0.064 mmol, 80% yield) as a yellow solid: R f = 0. 3-(1-(4-(3-(3-carboxy-4-(6-hydroxy-3-oxo-3H-xanthen-9-yl) N-((endo)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)-1-(4-((7-nitrobenzo[c][1,2,5] 
oxadiazol-4-yl)amino)butyl)-1H-indazole-3-carboxamide (19)
To a solution of 12•2 HCl (0.1 g, 0.23 mmol) in DMF/THF/H 2 O (1:4:2, 6.0 ml) solid Na 2 CO 3 was added and stirred at room temperature for 10 min. Then a solution of NBD chloride (0.09 g, 0.45 mmol) in THF (2 ml) was added to the mixture and stirred at 45 °C for 12 h. The solvents were removed in vacuo and the crude product was purified by flash column chromatography ( 
2-(2-(2-hydroxyethoxy)ethoxy)ethyl methanesulfonate
Triethylene glycol (4 g, 26.64 mmol, 3.6 ml) was dissolved in dry CH 2 Cl 2 (62 ml). The solution was cooled to 0°C before adding silver(I)oxide (6.8 g, 29.3 mmol, 1.1 eq.), followed by MsCl (2.5 ml, 31.97 mmol, 1.2 eq.). The mixture was stirred at room temperature for 5 d. Progress of the reaction was followed by TLC. It was then filtered through celite and the solvent was evaporated. The crude product was purified by flash chromatography on silica gel (EtOAc/MeOH, 95:5). The bismesylated product eluted first followed by the title compound. Colorless oil (4.54 g, 75% yield): R f = 0. 58 
2-(2-(2-azidoethoxy)ethoxy)ethanol
2-(2-(2-hydroxyethoxy)ethoxy)ethylmethane sulfonate (4.54 g, 19.8 mmol) was dissolved in DMF (50 ml) under stirring. NaN 3 (1.93 g, 29.7 mmol, 1.5 eq.) was added and the mixture was heated at 100°C under reflux for 18 h. Progress of the reaction was followed by TLC. The solution was cooled to room temperature and water (25 ml) was added, the aqueous phase was extracted with EtOAc (3×25 ml). The combined organic layers were washed with water (25 ml) and brine (25 ml). They were dried over MgSO 4 
2-(2-(2-aminoethoxy)ethoxy)ethanol
2-(2-(2-azidoethoxy)ethoxy)ethanol (0.7 g, 3.99 mmol) was dissolved in MeOH (9 ml), then palladium on activated carbon (0.196 g) was added under stirring. The flask was submitted to 3 evacuation/H 2 flushing cycles in order to establish the hydrogen atmosphere in the flask. The reaction was followed by TLC and showed completion after 8 h. The solution was filtered through celite to remove the Pd/C. 
tert-Butyl (2-(2-(2-hydroxyethoxy)ethoxy)ethyl)carbamate
2-(2-(2-aminoethoxy)ethoxy)ethanol (0.6 g, 4.062 mmol) was dissolved in acetonitrile (25 ml). The solution was cooled to 0°C and Et 3 N (1.13 ml, 8.12 mmol, 2 eq.) was added followed by Boc 2 O (0.268 g, 1.23 mmol). The reaction was followed by TLC and stirred overnight at room temperature. Water (15 ml) was added and the solution was extracted with EtOAc (3×30 ml), brine was used to help separating the two layers (5 ml) and also (30 ml) for washing. The combined organic layers were dried over Na 2 SO 4 , filtered and concentrated under reduced pressure. The crude product was purified by flash chromatography on silica gel (CH 2 Cl 2 /MeOH, 96:4) to give the title compound as a yellow oil (0.670 g, 66 % yield): R f = 0.46 (CH 2 Cl 2 /MeOH, 9.6:0.4 
tert-Butyl (2-(2-(2-bromoethoxy)ethoxy)ethyl)carbamate (10)
tert-butyl(2-(2-(2-hydroxyethoxy)ethoxy)ethyl)carbamate (0.5 g, 2.03 mmol) was dissolved in dry THF (20 ml) then Ph 3 P (1.06 g, 4.06 mmol, 2 eq.) was added. CBr 4 (1.35 g, 4.06 mmol, 2 eq.) was slowly added to the mixture. After 3 h the solution was filtered through celite to eliminate the phosphine oxide and washed with Et 2 O. The solvents were removed under high vacuum. The crude product was purified by flash chromatography on silica gel (hexane/AcOEt, 4:1) to give 10 as a colorless oil (0.601 g, 95% yield): R f = 0.42 (hexane/AcOEt, 4:1 (2-(2-(2-(3-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl) 
tert-Butyl
S3
To a stirred solution of amide 7 (0.057 g, 0.19 mmol, 1 eq.) in DMF (2 ml), linker 10 (0.095 g, 0.3 mmol, 1.6 eq.) was added, followed by K 2 CO 3 (0.047 g, 0.34 mmol, 1.8 eq.) and n-Bu 4 NI (0.007 g, 0.019 mmol, 10 mol%) at RT. After stirring overnight at 60°C, the reaction mixture was partitioned between EtOAc-water, the organic layer was washed with sat. NH 4 Cl, sat. NaHCO 3 and brine, dried over MgSO 4 
1-(2-(2-(2-Aminoethoxy)ethoxy)ethyl)-N-(9-methyl-9-azabicyclo[3.3.1] nonan-3-yl)-1H-indazole-3-carboxamide dihydrochloride (13)
tert-butyl (2-(2-(2-(3-(9-methyl-9-azabicyclo-[3.3.1]nonan-3-yl)carbamoyl)-1H-indazol-1-yl)ethoxy)ethoxy)-ethyl)carbamate (0.157 g, 0.295 mmol) was dissolved in dioxane (1.5 ml). HCl 4M in dioxane (1.47 ml, 5.9 mmol, 20 eq.) was then added. The mixture was stirred at RT for 4 h, the solvent was removed under high vacuum and co-evaporated 3 
1-(2-(2-(2-(7-(Diethylamino)-2-oxo-2H-chromene-3-carboxamido) ethoxy) ethoxy) ethyl)-N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)-1H-indazole-3-carboxamide (20)
Following procedure I: coumarin carboxylic acid (0.02 g, 0.076 mmol, 1 eq.), DCC (0.02 g, 0.098 mmol, 1.3 eq.) and HOBt (0.01 g, 0.076 mmol, 1 eq.) were mixed in a two-neck round bottom flask in DMF/CH 2 Cl 2 . A solution of amine 13•2 HCl (0.042 g, 0.084 mmol, 1.1 eq.) mixed with Et 3 N (20 µl, 0.1 mmol, 2 eq.) in dry CH 2 Cl 2 was then added drop wise. After work-up, the combined organic layers were dried over Na 2 SO 4 , filtered and concentrated to yield the crude product. The crude product was further purified by flash chromatography on silica gel (CH 2 Cl 2 /MeOH/Et 3 N, 96:3:1). The product was then washed with water (4 ml), NaHCO 3 sat. 2,2,2-Trifluoroacetic acid salt with 2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)-5-(3-(2-(2-(2-(3-((9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)carbamoyl)-1H-indazol-1-yl)ethoxy)ethoxy)ethyl)thioureido)benzoic acid (21) To a stirred solution of amine 13•2 HCl (0.042 g, 0.084 mmol, 1 eq.) in DMF (1 ml) was added Et 3 N (60 µl, 0.418 mmol, 5 eq.) and fluorescein isothiocyanate (0.036 g, 0.092 mmol, 1.1 eq.). The mixture was stirred for 5.5 h at room temperature. The solvent was removed under high vacuum. The crude product was purified by prep-LC using a gradient of 100% A (100% water with 0. N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)-1-(3-thioxo-7,10-dioxa-2, 
2-(6-(Diethylamino)-3-(diethyliminio)-3H-xanthen-9-yl)benzoate compound with
4-diazadodecan-12-yl)-1H-indazole-3-carboxamide trifluoroacetic salt (22)
To a stirred solution of amine 13•2 HCl (0.025 g, 0.049 mmol, 1 eq.) in DMF (0.5 ml) was added Et 3 N (35 µl, 0.248 mmol, 5 eq.) and rhodamine B isothiocyanate (mixture of 5-and 6-isomers) (0.029 g, 0.055 mmol, 1.1 eq.). The mixture was stirred at room temperature. The reaction was followed by TLC and after showing completion, the solvent was S16 removed under high vacuum. The crude product was purified by prep-LC using a gradient of 100% A (100% water with 0.1% of trifluoroacetic acid) to 100% D (40% water with 60% acetonitrile and 0.1% trifluoroacetic acid). The product had a retention time of 21 min. The fractions collected were dried by lyophilization to give 22•TFA as a purple solid (0.011 g, 0.011 mmol, 23% yield). The product was a mixture of 5-and 6-rhodamine isomers: IR (neat): 2920, 1590, 1125, 670 cm -1 . To a stirred solution of alcohol 31 (0.064 g, 0.194 mmol, 1 eq.) in DMF (2 ml), tert-butyl (2-bromoethyl)carbamate (0.069 g, 0.31 mmol, 1.6 eq.) was added, followed by potassium carbonate (0.048 g, 0.348 mmol, 1.8 eq.) and n-Bu 4 NI (0.007 g, 0.019 mmol, 10 mol%) at room temperature. After stirring overnight at 60°C, the reaction mixture was partitioned between ethylacetate and water, the organic layer was washed with saturated aqueous NH 4 Cl, saturated aqueous NaHCO 3 and brine, dried over MgSO 4 and filtered. The solvent was removed in vacuo. The crude product was purified on Alox basic (CH 2 Cl 2 /MeOH, 9.9:0.1 then 9:1) to give 33 as a white solid (0.058 g, 0.123 mmol, 64% yield). R f = 0. 
7-(2-(7-(diethylamino)-2-oxo-2H-chromene-3-carboxamido)ethoxy)-1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)-1H-indazole-3-carboxamide (36)
Following procedure I: coumarin carboxylic acid (0.019 g, 0.072 mmol, 1 eq.), DCC (0.019 g, 0.093 mmol, 1.3 eq.) and HOBt (0.01 g, 0.072 mmol, 1 eq.) were mixed in a two-neck round bottom flask in DMF/CH 2 Cl 2 . A solution of above amine•2HCl (0.035 g, 0.079 mmol, 1.1 eq.) mixed with Et 3 N (20 µl, 0.143 mmol, 2 eq.) in dry CH 2 Cl 2 was then added dropwise. After work-up, the combined organic layers were dried over Na 2 SO 4 , filtered and concentrated to yield the crude product. The crude product was further purified by flash chromatography on silica gel (CH 2 Cl 2 /MeOH/Et 3 N, 96:3:1), the solvents were removed under reduced pressure. The product was then washed with water (4 ml), NaHCO 3 sat. (3-((1-methyl-3-((9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)carbamoyl)-1H-indazol-7-yl) Compound 34 (0.2 g, 0.42 mmol) was dissolved in dioxane (4 ml). HCl 4M in dioxane (2 ml, 8 mmol, 20 eq.) was then added. The mixture was stirred at room temperature for 4 h. The solvent was removed under high vacuum and co-evaporated 3 times with CH 2 Cl 2 . Following procedure I: coumarin carboxylic acid (0.023 g, 0.089 mmol, 1 eq.), DCC (0.024 g, 0.116 mmol, 1.3 eq.) and HOBt (0.012 g, 0.089 mmol, 1 eq.) were mixed in DMF/CH 2 Cl 2 . A solution of the amine dihydrochloride salt from the previous step (0.045 g, 0.098 mmol, 1.1 eq.) was mixed with Et 3 N (25 µl, 0.178 mmol, 2 eq.) in dry CH 2 Cl 2 and then added drop-wise. After work-up, the combined organic layers were dried over Na 2 SO 4 , filtered and concentrated to yield the crude product. The crude product was further purified by flash chromatography on silica gel (CH 2 Cl 2 /MeOH/Et 3 N, 96:3:1), the solvents were removed under reduced pressure. The product was then washed with water (4 ml), NaHCO 3 sat. (2-(2-(2-((1-methyl-3-(9-methyl-9-azabicyclo[3 To a stirred solution of alcohol 31 (0.106 g, 0.323 mmol, 1 eq.) in DMF (3 ml), linker 10 (0.161 g, 0.52 mmol, 1.6 eq.) was added, followed by K 2 CO 3 (0.08 g, 0.58 mmol, 1.8 eq.) and n-Bu 4 NI (0.012 g, 0.032 mmol, 10 mol%). After work-up, the crude product was purified on basic Alox (AcOEt followed by CH 2 Cl 2 /MeOH, 9:1) which yielded product 35 as a white solid (0.126 g, 0.323 mmol, 70% yield): R f = 0.5 (CH 2 Cl 2 /MeOH, 9:1) on Alox TLC. IR (film): 2360, 2345 cm -1 . 1 H-NMR (300 MHz, CD 3 OD): δ 7.74 (d, J = 8.2 Hz, 1H) ; 7.11 (pseudo-t, J = 7.9 Hz, 1H) ; 6.83 (d, J = 7.6 Hz, 1H) ; 4.56 (tt, J = 11.5, The method of choice for the determination of fluorescence quantum yields was to relate the quantum yield of the sample to that of a reference standard. S4 Measurements were done in MeOH (highest quality for analysis) and in pH 7 phosphate buffer solution at 20°C and 25°C depending on the standard used as reference. In order to avoid inner filter effects, the concentration of the samples was adjusted such that the absorbance was between 0.05 and 0.08 at and above the excitation wavelength. For all calculations the solvent background was subtracted from the sample. The equation used to relate these quantum yields is Φ Fx = [(A std (λ exc ) /A x (λ exc ))×(F x /F std )×(n x /n std ) 2 ]×Φ Fstd, where the subscript x refers to the unknown sample and the subscript std refers to the standard; Φ F is the fluorescence quantum yield, F is the integrated fluorescence intensity, A is the absorbance at the excitation wavelength and n is the refractive index of the solvent. The standards were chosen such that the absorbance of the standard was overlapping with the absorbance of the sample. The reference standards used were quinine sulphate in 0.5M H 2 SO 4 (Φ F = 0.54) S5 , coumarin 6 in acetonitrile (Φ F = 0.63) S6 , fluorescein in 0.1M NaOH (Φ F = 0.95) S7 and rhodamine B in ethanol (Φ F = 0.7) S8 .
tert-Butyl
(5) Radioligand binding and fluorescence microscopy
Materials, cell culture maintenance, receptor expression and radioligand binding for the binding affinity measurements were described previously. 13 For the fluorescence microscopy experiments COS-7 cells were transiently transfected with human 5-HT3A-myc cDNA (10 µg per transfection of 2 x 10 -6 cells) by electroporation (400 V, ∞ Ω, 125 µF), and grown on coverslips for 24 hours. Cells were washed with HBS then incubated with 100 nM of each probe (diluted in HBS) for 1 hour at room temperature in the dark. In some experiments 10 µM unlabelled ondansetron (OND) was co-incubated with the probes. Excess probe was removed by washing four times in HBS, and coverslips were placed in an imaging chamber with 1 ml HBS. Cells were then imaged using a fluorescence microscope set to the appropriate emission/excitation wavelengths. 
